Innovative Approaches to Detect and Treat Alzheimer's

The chapter explores cutting-edge research on detecting Alzheimer's disease early through a study focusing on toxic oligomers in cerebrospinal fluid and blood samples. It also discusses the formation of a company to advance technology for Alzheimer's and Parkinson's diagnostics and therapeutics. Additionally, the conversation sheds light on challenges in conducting clinical trials for Alzheimer's and the importance of intervening early with therapy.